BioNTech

Pfizer and BioNTech announced on Wednesday that they will work together to develop an MRNA vaccine for the viral infection called shingles. The pharmaceutical companies worked together to create the world's first fully-approved MRNA vaccine for the coronavirus in 2020. They...

Pfizer CEO Albert Bourla told CNBC on Thursday that we may need a fourth vaccine dose "faster" in order to combat the omicron variant of Covid-19. Bourla had previously said that he anticipated the fourth shot to only be necessary...

Delta plus , a new variant of the original Delta variation of the coronavirus, has spread around the world. Are our vaccines effective enough?

Greek scientists Bourla and Yancopoulos, along with Ugur Sahin will be honored with the Bishop Athenagoras Human Rights Award.

The United States may authorize Pfizer's vaccine for children aged 12 to 15 as soon as next week, CEO Albert Bourla said on Tuesday.

Pfizer-BioNTech is seeking European Union approval for a vaccine for children as the bloc shifts towards the company as a supplier.

Two of the largest cities in Germany suspended use of the AstraZeneca vaccine in those under 60 after increased reports of blood clotting.

In a very welcome announcement after an extraordinarily difficult year ravaged by the coronavirus pandemic, it was revealed on Monday afternoon that the European Medicines Agency has given the green light for the emergency use of the Pfizer/BioNTech coronavirus...

The approval of vaccines against Covid-19 and the beginning of their distribution bring some consolation this Christmas, but the increase in coronavirus cases worldwide is accompanied by the imposition of stricter restrictions on travel and family gatherings at this...

German Minister of Health Jens Spann stated on Tuesday that his country is counting on approving the coronavirus vaccine "before Christmas," as the EU body responsible for giving the green light will begin examining the vaccine on December 21. The...